Application of Oral Fluid Assays in Support of Mumps Rubella and Varicella Control Programs.

Sunday, 3rd of January 2016

Vaccines (Basel). 2015 Dec 9;3(4):988-1003. doi: 10.3390/vaccines3040988.

Application of Oral Fluid Assays in Support of Mumps Rubella and Varicella Control Programs.

Maple PA¹.

Abstract

Detection of specific viral antibody or nucleic acid produced by infection or immunization using oral fluid samples offers increased potential for wider population uptake compared to blood sampling. This methodology is well established for the control of HIV and measles infections but can also be applied to the control of other vaccine preventable infections and this review describes the application of oral fluid assays in support of mumps rubella and varicella national immunization programs. In England and Wales individuals with suspected mumps or rubella based on clinical presentation can have an oral fluid swab sample taken for case confirmation. Universal varicella immunization of children has led to a drastic reduction of chickenpox in those countries where it is used; however in England and Wales such a policy has not been instigated. Consequently in England and Wales most children have had chickenpox by age 10 years; however small but significant numbers of adults remain susceptible. Targeted varicella zoster virus (VZV) immunization of susceptible adolescents offers the potential to reduce the pool of susceptible adults and oral fluid determination of VZV immunity in adolescents is a potential means of identifying susceptible individuals in need of VZV vaccination. The main application of oral fluid testing is in those circumstances where blood sampling is deemed not necessary or is undesirable and when the documented sensitivity and specificity of the oral fluid assay methodology to be used is considered sufficient for the purpose intended.